News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
249,646 Results
Type
Article (13516)
Company Profile (17)
Press Release (236113)
Multimedia
Podcasts (12)
Webinars (7)
Section
Business (73179)
Career Advice (525)
Deals (12098)
Drug Delivery (33)
Drug Development (46897)
Employer Resources (57)
FDA (6158)
Job Trends (5514)
News (136115)
Policy (11172)
Tag
2024 BioCapital Digital (1)
2024 Biotech Bay Standard (2)
2024 Biotech Beach Standard (2)
2024 Genetown Standard (2)
Academia (1094)
Accelerated approval (3)
Adcomms (12)
Allergies (43)
Alliances (17339)
ALS (44)
Alzheimer's disease (665)
Antibody-drug conjugate (ADC) (56)
Approvals (6207)
Artificial intelligence (73)
Autoimmune disease (15)
Automation (1)
Bankruptcy (83)
Best Places to Work (4799)
BIOSECURE Act (9)
Biosimilars (46)
Biotechnology (25)
Bladder cancer (38)
Brain cancer (11)
Breast cancer (134)
Cancer (1223)
Cardiovascular disease (69)
Career advice (449)
Career pathing (7)
CAR-T (73)
Cell therapy (186)
Cervical cancer (12)
Clinical research (38529)
Collaboration (371)
Compensation (107)
Complete response letters (9)
COVID-19 (1021)
CRISPR (22)
C-suite (81)
Cystic fibrosis (39)
Data (1306)
Denatured (3)
Depression (21)
Diabetes (120)
Diagnostics (1800)
Digital health (9)
Diversity (3)
Diversity, equity & inclusion (10)
Drug discovery (47)
Drug pricing (14)
Drug shortages (12)
Duchenne muscular dystrophy (41)
Earnings (35688)
Editorial (11)
Employer branding (6)
Employer resources (43)
Events (33390)
Executive appointments (228)
FDA (6758)
Featured Employer (5)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (3)
Frontotemporal dementia (4)
Funding (312)
Gene editing (54)
Generative AI (6)
Gene therapy (108)
GLP-1 (397)
Government (1620)
Grass and pollen (1)
Guidances (30)
Healthcare (7231)
Huntington's disease (9)
IgA nephropathy (13)
Immunology and inflammation (73)
Indications (16)
Infectious disease (1081)
Inflammatory bowel disease (94)
Inflation Reduction Act (1)
Influenza (24)
Intellectual property (48)
Interviews (83)
IPO (6882)
IRA (8)
Job creations (937)
Job search strategy (390)
Kidney cancer (6)
Labor market (19)
Layoffs (159)
Leadership (7)
Legal (1556)
Liver cancer (34)
Lung cancer (191)
Lymphoma (92)
Machine learning (1)
Management (15)
Manufacturing (116)
MASH (44)
Medical device (3987)
Medtech (3988)
Mergers & acquisitions (5462)
Metabolic disorders (334)
Multiple sclerosis (62)
NASH (12)
Neurodegenerative disease (43)
Neuropsychiatric disorders (11)
Neuroscience (973)
NextGen: Class of 2025 (2080)
Non-profit (1391)
Northern California (1241)
Now hiring (11)
Obesity (179)
Opinion (63)
Ovarian cancer (56)
Pain (38)
Pancreatic cancer (46)
Parkinson's disease (89)
Partnered (8)
Patents (103)
Patient recruitment (56)
Peanut (25)
People (17925)
Pharmaceutical (6)
Phase I (12778)
Phase II (17460)
Phase III (12056)
Pipeline (785)
Policy (33)
Postmarket research (1079)
Preclinical (5304)
Press Release (9)
Prostate cancer (55)
Psychedelics (14)
Radiopharmaceuticals (121)
Rare diseases (178)
Real estate (1490)
Recruiting (19)
Regulatory (8929)
Reports (32)
Research institute (982)
Resumes & cover letters (69)
Rett syndrome (3)
RNA editing (2)
RSV (17)
Schizophrenia (40)
Series A (55)
Series B (31)
Service/supplier (3)
Sickle cell disease (26)
Southern California (1017)
Special edition (7)
Spinal muscular atrophy (72)
Sponsored (12)
Startups (1152)
Stomach cancer (7)
Supply chain (28)
Tariffs (10)
The Weekly (9)
United States (9845)
Vaccines (223)
Venture capitalists (19)
Weight loss (122)
Women's health (9)
Worklife (6)
Date
Last 7 days (209)
Last 30 days (1045)
Last 365 days (15721)
2025 (4315)
2024 (16784)
2023 (19042)
2022 (24376)
2021 (25671)
2020 (23228)
2019 (17405)
2018 (13202)
2017 (13231)
2016 (11592)
2015 (13596)
2014 (9288)
2013 (6779)
2012 (7063)
2011 (7479)
2010 (6581)
Location
Africa (191)
Alabama (18)
Alaska (2)
Arizona (37)
Arkansas (5)
Asia (16897)
Australia (3086)
California (2691)
Canada (999)
China (266)
Colorado (114)
Connecticut (126)
Delaware (82)
Europe (37080)
Florida (405)
Georgia (75)
Idaho (23)
Illinois (186)
India (10)
Indiana (139)
Iowa (2)
Japan (98)
Kansas (53)
Kentucky (9)
Louisiana (5)
Maine (14)
Maryland (354)
Massachusetts (1939)
Michigan (57)
Minnesota (159)
Mississippi (1)
Missouri (25)
Montana (16)
Nebraska (2)
Nevada (33)
New Hampshire (15)
New Jersey (833)
New Mexico (8)
New York (863)
North Carolina (411)
North Dakota (2)
Northern California (1241)
Ohio (60)
Oklahoma (3)
Oregon (19)
Pennsylvania (514)
Puerto Rico (4)
Rhode Island (7)
South America (307)
South Carolina (2)
Southern California (1017)
Tennessee (43)
Texas (386)
Utah (61)
Virginia (48)
Washington D.C. (26)
Washington State (272)
West Virginia (1)
Wisconsin (13)
249,646 Results for "active motif".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Motif Neurotech Wins UK Government Award to Develop Therapeutic Brain-Computer Interface
January 20, 2025
·
3 min read
Lone Star Bio
Motif Neurotech Raises $18.75 Million in Series A Financing to Advance Implantable Device for Treatment-Resistant Depression
Motif Neurotech announced today an oversubscribed Series A financing of $18.75 million led by Arboretum Ventures.
January 24, 2024
·
3 min read
Business
Motif Neurotech Strengthens Leadership Team with Appointment of Steven Goetz as Chief Technology Officer
Motif Neurotech , a clinical-stage company developing minimally invasive bioelectronics for mental health, announces the appointment of Steven Goetz as Chief Technology Officer.
July 24, 2023
·
4 min read
Lone Star Bio
Motif Neurotech Conducts First-in-human Brain Stimulation With Millimeter-sized Implantable Device for Treatment-resistant Depression
Motif Neurotech, a neurotechnology company developing minimally invasive bioelectronics for mental health, announced today new research published to the preprint server medrxiv that demonstrates a millimeter-sized brain stimulator in a human subject.
September 18, 2023
·
5 min read
Deals
Active Motif Incorporated Announces the Acquisition of Amaryllis Nucleics and their proprietary RNASeq workflow
Active Motif Incorporated, a company with the vision of bringing epigenetics more deeply into precision medicine, announced that it has purchased Amaryllis Nucleics, a Bay Area-based start-up company focused on proprietary RNA Sequencing methods.
January 27, 2022
·
1 min read
Press Releases
Inhibikase Therapeutics Announces 2024 Financial Results and Highlights Recent Activity
March 28, 2025
·
7 min read
NextGen
Delphia Eyes New Precision Medicine Approach: Activation Lethality
Delphia launched in May 2024 with the goal of forcing malignant cells to overactivate and die.
March 4, 2025
·
2 min read
·
Annalee Armstrong
Press Releases
TREMFYA® (guselkumab) receives positive CHMP opinion for treatment of patients with moderately to severely active Crohn’s Disease
March 31, 2025
·
13 min read
Press Releases
University Hospitals Cleveland Medical Center Activates AI for Early Lung Cancer Identification
April 2, 2025
·
4 min read
Press Releases
AC Immune Announces Upcoming Presentations and Industry Symposium on Active Immunotherapies at AD/PD™ 2025
March 26, 2025
·
5 min read
1 of 24,965
Next
